CEI
COLL icon

Clark Estates Inc’s Collegium Pharmaceutical COLL Stock Holding History

Clark Estates Inc’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70,000
Closed -$1.24M – 89
2022
Q2 		$1.24M Sell
70,000
-113,800
-62% -$1.91M 0.21% 90
2022
Q1 		$3.74M Hold
183,800
– – 0.59% 58
2021
Q4 		$3.43M Hold
183,800
– – 0.5% 76
2021
Q3 		$3.63M Buy
+183,800
New +$3.97M 0.52% 74

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clark Estates Inc's COLL Position: Q3 2022 in Review

Clark Estates Inc sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 70,000 shares — an estimated $1.24M sold.

Clark Estates Inc first reported a position in COLL in Q3 2021 and held it in 4 quarters. The position peaked at $3.74M in Q1 2022. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

  • Clark Estates Inc reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Clark Estates Inc sold 70,000 Collegium Pharmaceutical shares in Q3 2022, an estimated $1.24M.
  • Clark Estates Inc first reported a position in Collegium Pharmaceutical in Q3 2021 and held it in 4 quarters.
  • Clark Estates Inc's Collegium Pharmaceutical position peaked at $3.74M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on Clark Estates Inc's 13F filing for Q3 2022, filed 14 Nov 2022.